Last reviewed · How we verify

NCT05326763

Functional and Electromyographical Changes After PRP or Dextrose Injection in Chronic Lateral Epicondylitis

Status unknown Phase 3 Last updated 14 April 2022
What this trial tests

Phase 3 trial testing Platelet Rich Plasma in Tennis Elbow in 90 participants. Status unknown.

Timeline
25 May 2021
Primary endpoint
31 December 2022
31 December 2022

Quick facts

Lead sponsorChen Yueh
PhasePhase 3
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment90
Start date25 May 2021
Primary completion31 December 2022
Estimated completion31 December 2022
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Chen Yueh

Who can join

Adults 20 to 65, any sex, with Tennis Elbow. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to find out functional and electromyographical changes after platelet rich plasma and dextrose injection in chronic lateral epicondylitis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Platelet Rich Plasma

Trials testing the same drug.

Other recruiting trials for Tennis Elbow

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05326763.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing